Intervention

semaglutide

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 84 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials84
Recruiting9
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
A Study of BGM0504 in Early T2DM With ObesityNCT07743983 · 2026-08-30
RECRUITING
Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderNCT07213466 · 2026-01-19
RECRUITING
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 SemaglutideNCT07040592 · 2026-01-15
RECRUITING
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DMNCT07314684 · 2025-09-08
RECRUITING
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated HemoglobinNCT07621419 · 2025-08-04
RECRUITING
Protein Supplementation Intervention on Body WeightNCT06989203 · 2025-06-10
RECRUITING
Probiotic Intervention on Body WeightNCT06989177 · 2025-06-10
RECRUITING
Effect of Semaglutide in Patients With Psoriasis and ObesityNCT06937060 · 2025-03-20
RECRUITING
The Impact of Semaglutide Compared to Energy Restriction on Type 2 DiabetesNCT07272343 · 2023-02-10
RECRUITING
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)NCT07812597 · 2026-10-12
NOT_YET_RECRUITING
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 DiabetesNCT07485062 · 2026-09-01
NOT_YET_RECRUITING
Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossNCT07592546 · 2026-08-01
NOT_YET_RECRUITING
A Study of CS060380 Tablets in Patients With MASH and ObesityNCT07466017 · 2026-04-02
ACTIVE_NOT_RECRUITING
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot StudiesNCT07483801 · 2026-03-01
NOT_YET_RECRUITING
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart ValvesNCT07610174 · 2025-06-02
COMPLETED
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)NCT06884293 · 2025-05-09
ACTIVE_NOT_RECRUITING
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes MellitusNCT06778967 · 2025-02-13
ACTIVE_NOT_RECRUITING
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)NCT06764056 · 2025-01-01
NOT_YET_RECRUITING
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in KoreaNCT07018544 · 2024-11-19
ENROLLING_BY_INVITATION
Semaglutide in Treatment of ObesityNCT06604624 · 2024-09-20
COMPLETED
A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.NCT07836140 · 2024-04-22
COMPLETED
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)NCT06959784 · 2024-01-01
ENROLLING_BY_INVITATION
Semaglutide and Intestinal Iron AbsorptionNCT06629688 · 2023-11-01
COMPLETED
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906NCT05751226 · 2023-04-11
COMPLETED
A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherNCT05435677 · 2022-06-22
COMPLETED
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)NCT05035082 · 2021-09-01
COMPLETED
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityNCT04940078 · 2021-07-07
COMPLETED
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®NCT04469855 · 2020-07-27
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)NCT04261933 · 2020-02-13
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)NCT04083820 · 2019-09-16
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)NCT03929679 · 2019-05-28
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinNCT03021187 · 2017-02-02
COMPLETED
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesNCT02692716 · 2017-01-17
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentNCT02827708 · 2016-09-20
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyNCT02906930 · 2016-09-20
COMPLETED
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.NCT02849080 · 2016-09-20
COMPLETED
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.NCT02877355 · 2016-08-22
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusNCT02863419 · 2016-08-10
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes MellitusNCT02863328 · 2016-08-10
COMPLETED
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal FemalesNCT02845219 · 2016-07-01
COMPLETED
A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 DiabetesNCT02773381 · 2016-06-02
COMPLETED
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 DiabetesNCT02607865 · 2016-02-15
COMPLETED
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.NCT02648204 · 2016-01-06
COMPLETED
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes MellitusNCT02453711 · 2015-10-01
COMPLETED
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesNCT02461589 · 2015-09-21
COMPLETED
Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once WeeklyNCT02557620 · 2015-09-01
COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 DiabetesNCT02305381 · 2014-12-01
COMPLETED
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 DiabetesNCT02254291 · 2014-10-02
COMPLETED
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy SubjectsNCT02249871 · 2014-09-24
COMPLETED
Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy SubjectsNCT02249910 · 2014-09-18
COMPLETED
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy SubjectsNCT02243098 · 2014-09-16
COMPLETED
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of SemaglutideNCT02231684 · 2014-09-01
COMPLETED
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesNCT02212067 · 2014-08-11
COMPLETED
Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionNCT02210871 · 2014-08-07
COMPLETED
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesNCT02128932 · 2014-08-04
COMPLETED
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 DiabetesNCT02207374 · 2014-08-04
COMPLETED
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy SubjectsNCT02172313 · 2014-06-01
COMPLETED
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian SubjectsNCT02161588 · 2014-06-01
COMPLETED
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian SubjectsNCT02146079 · 2014-05-21
COMPLETED
A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 DiabetesNCT02147431 · 2014-05-21
COMPLETED

Common conditions

Leading sponsors

Trial status mix

COMPLETED65
RECRUITING9
NOT_YET_RECRUITING5
ACTIVE_NOT_RECRUITING3
ENROLLING_BY_INVITATION2

Phase mix

PHASE135
PHASE322
PHASE29
PHASE48
NA4
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.